Candidiasis Therapeutics Market growth at a rate of 5.10% in the forecast period of 2021 to 2028
Introduction The global candidiasis therapeutics market is gaining momentum due to the increasing prevalence of fungal infections, particularly among immunocompromised populations. Candidiasis is primarily caused by Candida species, a type of yeast that resides in the body and can lead to infections when the immune system is compromised. The rise in conditions such as cancer, HIV/AIDS, diabetes, and the use of immunosuppressive drugs has increased susceptibility to candidiasis, thereby driving demand for effective therapeutic solutions. Market Overview Candidiasis manifests in various forms including oral thrush, vaginal yeast infections, and invasive candidiasis. The severity and site of infection influence treatment modalities, which include azoles, echinocandins, and polyenes. The global market is expected to expand steadily, supported by a growing geriatric population, higher rates of hospital-acquired infections, and a surge in awareness and diagnosis of fungal i...